methylmalonic acidaemia and propionic acidaemia
Metabolic · 2015–2024
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine Dietary management of patients with a proven diagnosis of methylmalonic acidaemia (MMA) or propionic acidaemia (PA). | Nov 2024 | Recommended | none received |
| Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine Dietary management of methylmalonic acidaemia and propionic acidaemia in young children. | Nov 2015 | Recommended with restriction | none received |
What the PBS pays
$17M in government benefit over 2024–25, across 16,208 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine | $17M |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.